Literature DB >> 19251098

A comprehensive assessment by tumor site of patient setup using daily MVCT imaging from more than 3,800 helical tomotherapy treatments.

Leah K Schubert1, David C Westerly, Wolfgang A Tomé, Minesh P Mehta, Emilie T Soisson, Thomas R Mackie, Mark A Ritter, Deepak Khuntia, Paul M Harari, Bhudatt R Paliwal.   

Abstract

PURPOSE: To assess patient setup corrections based on daily megavoltage CT (MVCT) imaging for four anatomic treatment sites treated on tomotherapy. METHOD AND MATERIALS: Translational and rotational setup corrections, based on registration of daily MVCT to planning CT images, were analyzed for 1,179 brain and head and neck (H&N), 1,414 lung, and 1,274 prostate treatment fractions. Frequencies of three-dimensional vector lengths, overall distributions of setup corrections, and patient-specific distributions of random and systematic setup errors were analyzed.
RESULTS: Brain and H&N had lower magnitude positioning corrections and smaller variations in translational setup errors but were comparable in roll rotations. Three-dimensional vector translational shifts of larger magnitudes occurred more frequently for lung and prostate than for brain and H&N treatments, yet this was not observed for roll rotations. The global systematic error for prostate was 4.7 mm in the vertical direction, most likely due to couch sag caused by large couch extension distances. Variations in systematic errors and magnitudes of random translational errors ranged from 1.6 to 2.6 mm for brain and H&N and 3.2 to 7.2 mm for lung and prostate, whereas roll rotational errors ranged from 0.8 degrees to 1.2 degrees for brain and H&N and 0.5 degrees to 1.0 degrees for lung and prostate.
CONCLUSIONS: Differences in setup were observed between brain, H&N, lung, and prostate treatments. Patient setup can be improved if daily imaging is performed. This analysis can assess the utilization of daily image guidance and allows for further investigation into improved anatomic site-specific and patient-specific treatments.

Entities:  

Mesh:

Year:  2009        PMID: 19251098      PMCID: PMC2749998          DOI: 10.1016/j.ijrobp.2008.11.054

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  20 in total

Review 1.  Set-up error & organ motion uncertainty: a review.

Authors:  J T Booth; S F Zavgorodni
Journal:  Australas Phys Eng Sci Med       Date:  1999-06       Impact factor: 1.430

2.  Tomotherapy.

Authors:  T R Mackie; J Balog; K Ruchala; D Shepard; S Aldridge; E Fitchard; P Reckwerdt; G Olivera; T McNutt; M Mehta
Journal:  Semin Radiat Oncol       Date:  1999-01       Impact factor: 5.934

Review 3.  Organ motion and its management.

Authors:  K M Langen; D T Jones
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-05-01       Impact factor: 7.038

Review 4.  Errors and margins in radiotherapy.

Authors:  Marcel van Herk
Journal:  Semin Radiat Oncol       Date:  2004-01       Impact factor: 5.934

Review 5.  Advances in image-guided radiation therapy.

Authors:  Laura A Dawson; David A Jaffray
Journal:  J Clin Oncol       Date:  2007-03-10       Impact factor: 44.544

6.  The utility of megavoltage computed tomography images from a helical tomotherapy system for setup verification purposes.

Authors:  Lisa J Forrest; Thomas Rockwell Mackie; Ken Ruchala; Michelle Turek; Jeff Kapatoes; Hazim Jaradat; Susanta Hui; John Balog; David M Vail; Minesh P Mehta
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-12-01       Impact factor: 7.038

7.  Adaptive modification of treatment planning to minimize the deleterious effects of treatment setup errors.

Authors:  D Yan; J Wong; F Vicini; J Michalski; C Pan; A Frazier; E Horwitz; A Martinez
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-04-01       Impact factor: 7.038

8.  The impact of daily setup variations on head-and-neck intensity-modulated radiation therapy.

Authors:  Theodore S Hong; Wolfgang A Tomé; Richard J Chappell; Prakash Chinnaiyan; Minesh P Mehta; Paul M Harari
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-03-01       Impact factor: 7.038

9.  Megavoltage computed tomography imaging: a potential tool to guide and improve the delivery of thoracic radiation therapy.

Authors:  James S Welsh; Kristin Bradley; Kenneth J Ruchala; Thomas R Mackie; Rafael Mañon; Rakesh Patel; Peggy Wiederholt; Michael Lock; Susanta Hui; Minesh P Mehta
Journal:  Clin Lung Cancer       Date:  2004-03       Impact factor: 4.785

10.  The impact of daily shifts on prostate IMRT dose distributions.

Authors:  Nigel P Orton; Wolfgang A Tomé
Journal:  Med Phys       Date:  2004-10       Impact factor: 4.071

View more
  27 in total

1.  Rotational output and beam quality evaluations for helical tomotherapy with use of a third-party quality assurance tool.

Authors:  Hidetoshi Shimizu; Koji Sasaki; Manabu Iwata; Minoru Kawai; Kuniyasu Nakashima; Takashi Kubota; Hikaru Osaki; Masashi Nakayama; Manabu Yoshimoto; Takeshi Kodaira
Journal:  Radiol Phys Technol       Date:  2015-08-23

2.  The potential of helical tomotherapy in the treatment of head and neck cancer.

Authors:  Dirk Van Gestel; Dirk Verellen; Lien Van De Voorde; Bie de Ost; Geert De Kerf; Olivier Vanderveken; Carl Van Laer; Danielle Van den Weyngaert; Jan B Vermorken; Vincent Gregoire
Journal:  Oncologist       Date:  2013-05-30

3.  IMRT and IGRT in head and neck cancer: Have we delivered what we promised?

Authors:  Gupta Tejpal; Agarwal Jaiprakash; Bannerjee Susovan; Sarbani Ghosh-Laskar; Vedang Murthy; Ashwini Budrukkar
Journal:  Indian J Surg Oncol       Date:  2010-11-21

4.  Set-up errors and planning target volume margins in head and neck cancer radiotherapy: a clinical study of image guidance with on-line cone-beam computed tomography.

Authors:  Francesco Dionisi; Mauro Filippo Palazzi; Francesco Bracco; Maria Grazia Brambilla; Claudia Carbonini; Diego Dario Asnaghi; Angelo Filippo Monti; Alberto Torresin
Journal:  Int J Clin Oncol       Date:  2012-03-03       Impact factor: 3.402

5.  Helical tomotherapy setup variations in canine nasal tumor patients immobilized with a bite block.

Authors:  Lyndsay N Kubicek; Songwon Seo; Richard J Chappell; Robert Jeraj; Lisa J Forrest
Journal:  Vet Radiol Ultrasound       Date:  2012-06-25       Impact factor: 1.363

6.  Three-dimensional patient setup errors at different treatment sites measured by the Tomotherapy megavoltage CT.

Authors:  S K Hui; E Lusczek; T DeFor; K Dusenbery; S Levitt
Journal:  Strahlenther Onkol       Date:  2012-03-09       Impact factor: 3.621

7.  Adaptive radiotherapy for head-and-neck cancer: initial clinical outcomes from a prospective trial.

Authors:  David L Schwartz; Adam S Garden; Jimmy Thomas; Yipei Chen; Yongbin Zhang; Jan Lewin; Mark S Chambers; Lei Dong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-12-02       Impact factor: 7.038

8.  Multi-institutional feasibility study of a fast patient localization method in total marrow irradiation with helical tomotherapy: a global health initiative by the international consortium of total marrow irradiation.

Authors:  Yutaka Takahashi; Stefano Vagge; Stefano Agostinelli; Eunyoung Han; Lukasz Matulewicz; Kai Schubert; Ravishankar Chityala; Vaneerat Ratanatharathorn; Koen Tournel; Jose A Penagaricano; Sterzing Florian; Marc-Andre Mahe; Michael R Verneris; Daniel J Weisdorf; Renzo Corvo; Kathryn E Dusenbery; Guy Storme; Susanta K Hui
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-10-30       Impact factor: 7.038

9.  Clinical challenges in the implementation of a tomotherapy service for head and neck cancer patients in a regional UK radiotherapy centre.

Authors:  S Chatterjee; J H Mott; G Smyth; S Dickson; W Dobrowsky; C G Kelly
Journal:  Br J Radiol       Date:  2010-12-15       Impact factor: 3.039

10.  Setup margins and geometric uncertainties in intensity-modulated radiation therapy in treating pituitary adenomas: the experience of Lyon Sud Hospital.

Authors:  B De Bari; I Shakir Shakir; T Chekrine; L Lestrade; V Favrel
Journal:  Radiol Med       Date:  2012-10-22       Impact factor: 3.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.